Behavior Science Technology

Name: Behavior Science Technology
Brand: Behavior Science Technology
Rating: 4.1 (10 reviews)

Stop the turnover. Start measuring procedural integrity.

Est 2019|Valuation $4M|Raised $1.4M|1 Ref Customers

LinkedIn 5K|Website|FTEs 3|HQ Fort Lauderdale, Florida, US

Published Oct 15, 2026

01Common complaints

- You need a full ABA EMR / scheduling / billing platform in one tool: consider CentralReach, RethinkBH, or other all-in-one practice management systems. - You require publicly documented compliance posture (SOC 2, HIPAA documentation, or detailed security whitepapers) before engaging sales. If the vendor cannot provide these under NDA, the risk may be unacceptable. - Your organization lacks supervision capacity: a fidelity program requires supervisors to observe, coach, and close gaps. - You require broad marketplace integrations out-of-the-box: integration documentation is not clearly published, so validate fit early.

Deal disqualifiers

Organizations needing a complete EMR + billing + scheduling solution in a single product (BSTperform is not positioned as a full EMR).
Teams unwilling or unable to allocate supervisor time for consistent observation and coaching.
Procurement requiring publicly documented third-party security certifications and detailed security materials prior to engagement.

Known limitations based on public information

Security/compliance details (SOC 2/ISO/HIPAA) are not prominently published on public pages.
Limited independent review coverage on mainstream B2B review sites for this specific product.
Integration details (supported EMRs, data collection apps, data warehouse exports) are not clearly documented publicly.

Roadmap / future state signals

Public sources indicate intent to integrate BSTperform into CentralReach’s Care360 platform over time, which may change product packaging and workflows.

02Why they buy

Unique selling points supported by available evidence

Treatment fidelity / procedural integrity is a primary organizing metric in BSTperform’s product messaging and materials.
Published pricing tiers for common organization sizes provide a level of price transparency uncommon in some ABA enterprise vendors.

Marketing claims requiring verification

CentralReach’s acquisition announcement references a claim that BSTperform increased behavior technician tenure by a stated factor. This outcome should be validated for methodology, baseline, sample size, and confounding variables before being used as a basis for procurement decisions.

03Field reports

Availability of third-party reviews (important limitation)

BSTperform / Behavior Science Technology has limited presence on major B2B review platforms in accessible sources: - Attempts did not surface a clearly relevant BSTperform profile on major review sites accessible for quotations. As a result, much of the public review evidence is: - vendor-hosted case studies and testimonials, - a small set of non-mainstream review aggregator content, - and broader community sentiment about CentralReach (the acquirer) and competing platforms.

Vendor-published testimonials / Customer Insights

BST’s site includes customer stories and a "Customer Insights" section; these are vendor-selected and not independently validated.

Example third-party review content (use with caution)

A non-mainstream review aggregator contains several broadly positive reviews for Behavior Science Technology; the language in those reviews is not highly specific to product functionality and some entries were flagged by the aggregator for unverified company information. Such sources should be weighted lightly compared with independently verified practitioner reviews.

Community / practitioner discussion signals (proxy evidence)

Direct community discussion specifically naming BSTperform was not prominent in accessible sources; however, community discussion about the broader ABA software ecosystem, especially CentralReach, is abundant: - Price sensitivity: community threads criticize CentralReach pricing in some cases. - Usability and workflow limitations: some users report friction with structured dropdown documentation and maintaining separate free-text logs. These discussions relate to CentralReach rather than BSTperform specifically, but they are relevant because BSTperform is now within CentralReach’s portfolio and future integration or packaging could affect pricing and user experience.

Inferred reasons customers might choose BSTperform

Based on vendor positioning and case studies, customers may select BSTperform when they:

require procedural integrity / fidelity measurement as a primary quality metric,
need reporting to identify supervision and training gaps,
want a standardized quality signal to support growth, payer scrutiny, or clinical governance.

Inferred reasons customers might discontinue

Public evidence of product-specific churn reasons is limited. Plausible risks include:

changes to packaging or pricing post-acquisition,
insufficient integrations with a customer’s core EMR/data collection stack.

Case Studies

BST publishes multiple case studies, including: - LEARN Behavioral — reported reduced employee turnover through treatment fidelity measurement. - Mississippi Behavior Services — reported a substantial reduction in turnover after addressing training gaps. - Aspen Behavioral Consulting — reported increased efficiency. Critical evaluation / methodology gaps: - These are vendor-published case studies. The materials do not clearly disclose baseline vs. post metrics definitions, time periods, control groups, confounding factors (pay changes, caseload changes, management changes), or statistical significance. - Claims such as reports of dramatically reduced turnover or large percentage improvements should be treated as context-specific unless independently validated.

04Best fit

Company size

Based on published tiers and positioning:

Best fit appears to be small-to-mid-sized ABA providers (multiple clinicians and supervisors; user-equivalent billing models may apply).
Larger organizations are supported through enterprise arrangements and typically require a customized contracting/pricing process.

Industries / verticals

ABA therapy providers (autism services organizations)
Behavioral health organizations using ABA methods

Roles / personas

Economic buyer: COO, CEO, VP Clinical Ops, Quality/Compliance leader
Champion: Clinical Director, operations or performance management leader
Daily user: BCBA supervisors conducting observations and reviewing fidelity dashboards

Pain points it addresses

Lack of standardized treatment fidelity measurement
Inconsistent supervision quality across locations/teams
Difficulty identifying training gaps early
Need for data-driven quality narratives for growth, audits, or payer scrutiny

05The pitch

What the product does (objective value proposition)

Behavior Science Technology (BST) offers BSTperform®, a SaaS product positioned as a treatment fidelity / procedural integrity measurement and analytics platform for Applied Behavior Analysis (ABA) providers. BSTperform is intended to support ABA organizations in the following activities: - collecting and aggregating treatment fidelity observations/assessments, - identifying skill/training gaps, - standardizing supervision and quality processes, - providing dashboards and BI reporting to inform decisions, - and, per vendor materials, supporting clinical outcome monitoring, operational measurement, and workforce retention efforts. BST describes BSTperform as data collection software focused on treatment fidelity visibility with dashboards and BI reporting.

Target market and positioning

Primary buyers: ABA provider executives/operations leaders, clinical directors, quality leaders.
Primary users: clinical supervisors/BCBAs (observation/assessment workflows), and potentially operations/quality teams (dashboards).
Market position: a quality/clinical-operations layer centered on fidelity measurement rather than a full EMR/billing system.

Get a comprehensive analysis of Behavior Science Technology including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Oct 15, 2026

01Common complaints

You need a full ABA EMR / scheduling / billing platform in one tool: consider CentralReach, RethinkBH, or other all-in-one practice management systems.
You require publicly documented compliance posture (SOC 2, HIPAA documentation, or detailed security whitepapers) before engaging sales. If the vendor cannot provide these under NDA, the risk may be unacceptable.
Your organization lacks supervision capacity: a fidelity program requires supervisors to observe, coach, and close gaps.
You require broad marketplace integrations out-of-the-box: integration documentation is not clearly published, so validate fit early.

Deal disqualifiers

Organizations needing a complete EMR + billing + scheduling solution in a single product (BSTperform is not positioned as a full EMR).
Teams unwilling or unable to allocate supervisor time for consistent observation and coaching.
Procurement requiring publicly documented third-party security certifications and detailed security materials prior to engagement.

Known limitations based on public information

Security/compliance details (SOC 2/ISO/HIPAA) are not prominently published on public pages.
Limited independent review coverage on mainstream B2B review sites for this specific product.
Integration details (supported EMRs, data collection apps, data warehouse exports) are not clearly documented publicly.

Roadmap / future state signals

Public sources indicate intent to integrate BSTperform into CentralReach’s Care360 platform over time, which may change product packaging and workflows.

02Why they buy

Unique selling points supported by available evidence

Treatment fidelity / procedural integrity is a primary organizing metric in BSTperform’s product messaging and materials.
Published pricing tiers for common organization sizes provide a level of price transparency uncommon in some ABA enterprise vendors.

Marketing claims requiring verification

CentralReach’s acquisition announcement references a claim that BSTperform increased behavior technician tenure by a stated factor. This outcome should be validated for methodology, baseline, sample size, and confounding variables before being used as a basis for procurement decisions.

03Field reports

Availability of third-party reviews (important limitation)

BSTperform / Behavior Science Technology has limited presence on major B2B review platforms in accessible sources:

Attempts did not surface a clearly relevant BSTperform profile on major review sites accessible for quotations.

As a result, much of the public review evidence is:

vendor-hosted case studies and testimonials,
a small set of non-mainstream review aggregator content,
and broader community sentiment about CentralReach (the acquirer) and competing platforms.

Vendor-published testimonials / Customer Insights

BST’s site includes customer stories and a "Customer Insights" section; these are vendor-selected and not independently validated.

Example third-party review content (use with caution)

Community / practitioner discussion signals (proxy evidence)

Price sensitivity: community threads criticize CentralReach pricing in some cases.
Usability and workflow limitations: some users report friction with structured dropdown documentation and maintaining separate free-text logs.

These discussions relate to CentralReach rather than BSTperform specifically, but they are relevant because BSTperform is now within CentralReach’s portfolio and future integration or packaging could affect pricing and user experience.

Inferred reasons customers might choose BSTperform

Based on vendor positioning and case studies, customers may select BSTperform when they:

require procedural integrity / fidelity measurement as a primary quality metric,
need reporting to identify supervision and training gaps,
want a standardized quality signal to support growth, payer scrutiny, or clinical governance.

Inferred reasons customers might discontinue

Public evidence of product-specific churn reasons is limited. Plausible risks include:

changes to packaging or pricing post-acquisition,
insufficient integrations with a customer’s core EMR/data collection stack.

Case Studies

BST publishes multiple case studies, including:

LEARN Behavioral — reported reduced employee turnover through treatment fidelity measurement.
Mississippi Behavior Services — reported a substantial reduction in turnover after addressing training gaps.
Aspen Behavioral Consulting — reported increased efficiency.

Critical evaluation / methodology gaps:

These are vendor-published case studies. The materials do not clearly disclose baseline vs. post metrics definitions, time periods, control groups, confounding factors (pay changes, caseload changes, management changes), or statistical significance.
Claims such as reports of dramatically reduced turnover or large percentage improvements should be treated as context-specific unless independently validated.

04Best fit

Company size

Based on published tiers and positioning:

Best fit appears to be small-to-mid-sized ABA providers (multiple clinicians and supervisors; user-equivalent billing models may apply).
Larger organizations are supported through enterprise arrangements and typically require a customized contracting/pricing process.

Industries / verticals

ABA therapy providers (autism services organizations)
Behavioral health organizations using ABA methods

Roles / personas

Economic buyer: COO, CEO, VP Clinical Ops, Quality/Compliance leader
Champion: Clinical Director, operations or performance management leader
Daily user: BCBA supervisors conducting observations and reviewing fidelity dashboards

Pain points it addresses

Lack of standardized treatment fidelity measurement
Inconsistent supervision quality across locations/teams
Difficulty identifying training gaps early
Need for data-driven quality narratives for growth, audits, or payer scrutiny

05The pitch

What the product does (objective value proposition)

collecting and aggregating treatment fidelity observations/assessments,
identifying skill/training gaps,
standardizing supervision and quality processes,
providing dashboards and BI reporting to inform decisions,
and, per vendor materials, supporting clinical outcome monitoring, operational measurement, and workforce retention efforts.

BST describes BSTperform as data collection software focused on treatment fidelity visibility with dashboards and BI reporting.

Target market and positioning

Primary buyers: ABA provider executives/operations leaders, clinical directors, quality leaders.
Primary users: clinical supervisors/BCBAs (observation/assessment workflows), and potentially operations/quality teams (dashboards).
Market position: a quality/clinical-operations layer centered on fidelity measurement rather than a full EMR/billing system.

Get a comprehensive analysis of Behavior Science Technology including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →